Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the
emergence and development of antiangiogenic therapies to eliminate bleeding …

Management of bleeding in hereditary hemorrhagic telangiectasia (HHT), the second most
common hereditary bleeding disorder in the world, is currently undergoing a paradigm shift …

Vascular anomalies represent a diverse group of disorders classified broadly as
malformations or tumors and include the second most common hereditary bleeding disorder …

Optimal management of complex vascular anomalies aims to not only treat acute issues,
such as infection or effusion, but also prevent potential future complications and improve …

Hereditary hemorrhagic telangiectasia is an inherited disease related to an alteration in
angiogenesis, manifesting as cutaneous telangiectasias and epistaxis. As complications, it …

Background Hereditary hemorrhagic telangiectasia (HHT) disease is a rare genetic disorder
with symptoms and complications that can significantly affect patients' daily lives. To date, no …

Nosebleeds and intracranial hemorrhage from brain arteriovenous malformations (bAVMs)
are among the most devastating symptoms of patients with hereditary hemorrhagic …

Background: Hereditary hemorrhagic telangiectasia (HHT) is a disease characterized by
arteriovenous malformations and telangiectases, in which the endothelium and immune …

Background Studies evaluating health-related quality of life (HRQOL) in patients with
hereditary hemorrhagic telangiectasia (HHT) have expanded rapidly in the past decade …

Purpose Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder that presents
with recurrent, intractable epistaxis. The aim of this study was to retrospectively analyze the …